Robert Clay Grant - Oct 28, 2024 Form 4 Insider Report for SelectQuote, Inc. (SLQT)

Role
PRESIDENT
Signature
/s/ Daniel A. Boulware, Attorney-in-Fact
Stock symbol
SLQT
Transactions as of
Oct 28, 2024
Transactions value $
$0
Form type
4
Date filed
10/30/2024, 04:59 PM
Previous filing
Aug 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLQT Restricted Stock Units Award $0 +367K $0.00 367K Oct 28, 2024 Common Stock, par value $0.01 per share 367K Direct F1, F2, F3
transaction SLQT Price-Vested Restricted Stock Units Award $0 +367K $0.00 367K Oct 28, 2024 Common Stock, par value $0.01 per share 367K Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units of SelectQuote, Inc. (the "Company") granted to the recipient pursuant to the Company's 2020 Omnibus Incentive Plan.
F2 Each restricted stock unit represents a contingent right to receive one share of the Company's common stock, par value $0.01 per share.
F3 The restricted stock units vest ratably in three annual installments commencing on August 1, 2025, subject to the recipient's continued employment with the Company through the applicable vesting date.
F4 Represents price-vested restricted stock units of the Company ("PVUs") granted to the recipient pursuant to the Plan.
F5 Each PVU represents the contingent right to receive one share of the Company's common stock, par value $0.01 per share, upon the Company's common stock reaching certain predetermined average trading prices, subject to applicable vesting conditions.
F6 The PVUs are eligible to vest in three ratable annual installments commencing on August 1, 2025, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-third of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock exceeding each of $3.13, $6.00, and $9.00 during the five-year performance period.